Technical Analysis for DXR - Daxor Corporation

Grade Last Price % Change Price Change
F 11.0 0.82% 0.09
DXR closed up 0.82 percent on Thursday, April 15, 2021, on 1.66 times normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical DXR trend table...

Date Alert Name Type % Chg
Doji - Bullish? Reversal 0.00%
Lower Bollinger Band Walk Weakness 0.00%
New 52 Week Low Weakness 0.00%
Up 3 Days in a Row Strength 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Lower Bollinger Band Walk Weakness 0.82%
Inside Day Range Contraction 0.82%
Oversold Stochastic Weakness 0.82%
Stochastic Buy Signal Bullish 1.15%
Older End-of-Day Signals for DXR ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above Lower Bollinger Band 7 days ago
Up 3% 7 days ago
Up 2% 7 days ago
Up 1% 7 days ago
Fell Below Previous Day's Low 7 days ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Daxor Corporation Description

Daxor Corporation, a medical device manufacturing company, offers biotech services in the United States. The company develops and markets BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients with heart failure, kidney failure, hypertension, and syncope; aid in fluid and blood transfusion management in the critical care unit; and aid in the diagnosis and treatment of disorders of red blood cell volume, including polycythemia and anemia, as well as used in pre-surgical evaluation of red blood cell volume. The company also provides cryobanking services, including blood and semen storage and related services. Daxor Corporation markets its products to hospitals and radiology imaging centers. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.


Classification

Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Hypertension Disorders Hematology Heart Failure Radiology Anemia Red Blood Cell Blood Transfusion Medicine Blood Transfusion Kidney Failure Science Medical Device Manufacturing Blood Volume Hematopathology Polycythemia Syncope

Is DXR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 24.0758
52 Week Low 10.6
Average Volume 13,309
200-Day Moving Average 14.31
50-Day Moving Average 12.29
20-Day Moving Average 11.87
10-Day Moving Average 11.42
Average True Range 0.69
ADX 13.77
+DI 13.67
-DI 22.13
Chandelier Exit (Long, 3 ATRs ) 11.38
Chandelier Exit (Short, 3 ATRs ) 12.66
Upper Bollinger Band 13.10
Lower Bollinger Band 10.63
Percent B (%b) 0.15
BandWidth 20.80
MACD Line -0.37
MACD Signal Line -0.26
MACD Histogram -0.1149
Fundamentals Value
Market Cap 42.78 Million
Num Shares 3.89 Million
EPS 0.05
Price-to-Earnings (P/E) Ratio 207.55
Price-to-Sales 98.79
Price-to-Book 4.99
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.83
Resistance 3 (R3) 11.78 11.47 11.69
Resistance 2 (R2) 11.47 11.26 11.49 11.64
Resistance 1 (R1) 11.23 11.13 11.35 11.28 11.60
Pivot Point 10.92 10.92 10.98 10.94 10.92
Support 1 (S1) 10.68 10.71 10.80 10.73 10.40
Support 2 (S2) 10.37 10.58 10.39 10.36
Support 3 (S3) 10.13 10.37 10.31
Support 4 (S4) 10.18